-

Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces

A revolutionary advancement in X-ray photoelectron spectroscopy (XPS) depth profiling

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the world.

Innovation to Improve Society
The Hypulse Surface Analysis System will enable the development of surfaces across industries to improve society — from advancing energy storage, to evolving medical implants, to enhancing fire protection. This new generation of XPS depth-profiling will enable researchers to extract more insights from surface samples and create better materials. In the case of medical implants, for example, these insights can pave the way for research that will help upgrade coatings for better biocompatibility, longevity and infection prevention.

Femtosecond Laser Technology: Insights Beyond the Surface
What sets the Thermo Scientific Hypulse Surface Analysis System apart is that it is equipped with a novel material-removal method: femtosecond laser technology. This allows researchers to preserve sample accuracy, accelerate data collection and characterize more materials at greater depths.

"The femtosecond laser has many advantages,” says Professor Mark Baker, surface science and engineering at the University of Surrey in the United Kingdom. “First, it enables us to avoid chemical damage because it changes the material-removal mechanism from a ballistic process to an electrostatic process, allowing us to record the original, true composition in the profile. Second, we can record depth much quicker. The third advantage is that we now have the ability to vary energy in the laser, enabling us to profile to greater depths.”

“With Hypulse, we’ve retained our industry-leading surface technology while pushing ourselves to meet customer needs of today and tomorrow,” says David Wall, vice president and general manager of materials science for Thermo Fisher Scientific. “We’ve combined our proven MAGCIS™ ion source with the femtosecond laser, so that our customers can examine samples when ion beam technology is not suitable.”

To learn more about the Thermo Scientific Hypulse Surface Analysis System, please visit our website or visit booth 601 at the AVS International Symposium and Exhibition in Charlotte, North Carolina, September 23-25.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom